Chempharm Industries India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
- Paid Up Capital ₹ 3.86 M
- Company Age 29 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.76 Cr
- Satisfied Charges ₹ 1.74 Cr
- Revenue Growth 73.32%
- Profit Growth 17.03%
- Ebitda 43.53%
- Net Worth 30.14%
- Total Assets -13.99%
About Chempharm Industries India
Chempharm Industries India Private Limited (CIIPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 20 April 1995 and has a history of 29 years and ten months. Its registered office is in New Delhi, Delhi.
The Corporate was formerly known as Chempharm Industries India Limited. The Company is engaged in the Consumer Electronics & Durables Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.86 M.
The company currently has active open charges totaling ₹9.76 Cr. The company has closed loans amounting to ₹1.74 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Sapra, Uditi Chadha, and Sahil Sapra serve as directors at the Company.
Company Details
- Location New Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1995PTC067567
- Company No.
067567
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Apr 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Chempharm Industries India Private Limited offer?
Chempharm Industries India Private Limited offers a wide range of products and services, including Face Mask & Medical PPE Kits, Mask Raw Material.
Who are the key members and board of directors at Chempharm Industries India?
Board Members (3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Anil Sapra ![]() | Director | 20-Apr-1995 | Current |
Uditi Chadha ![]() | Director | 01-Apr-2018 | Current |
Sahil Sapra ![]() | Director | 17-Dec-2013 | Current |
Financial Performance of Chempharm Industries India.
Chempharm Industries India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 73.32% increase. The company also saw a substantial improvement in profitability, with a 17.03% increase in profit. The company's net worth Soared by an impressive increase of 30.14%.


- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Chempharm Industries India?
In 2023, Chempharm Industries India had a promoter holding of 80.43% and a public holding of 19.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Charges (Loans)
₹97.62 M
₹17.42 M
Charges Breakdown by Lending Institutions
- Canara Bank : 9.76 Cr
Latest Charge Details
Date | Lender | Amount | Status |
---|---|---|---|
19 Jun 2024 | Canara Bank | ₹1.77 M | Open |
19 Jun 2024 | Canara Bank | ₹0.55 M | Open |
15 Apr 2020 | Canara Bank | ₹4.30 M | Open |
15 Apr 2020 | Canara Bank | ₹1.25 M | Open |
24 Mar 2000 | Canara Bank | ₹8.98 Cr | Open |
How Many Employees Work at Chempharm Industries India?
Chempharm Industries India has a workforce of 31 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Chempharm Industries India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chempharm Industries India's trajectory.
Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.